ALICIA BAROS: Open Payments
NPI 1710370069 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 13 payments from 8 companies in 2025. Trend: 2023 $1,570 · 2024 $955 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $126 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Lundbeck LLC | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Alkermes, Inc. | 1 | $15 |
Products named: AUSTEDO XR, Auvelity, INVEGA SUSTENNA, REXULTI, UZEDY, TRINTELLIX, CAPLYTA, ARISTADA.
Industry payments across AR — which companies pay providers there.
